102 related articles for article (PubMed ID: 32534715)
1. Prognostic significance of glucose-related protein 94 in colorectal cancer.
Lee JS; Roh MS; Lee HW; Lee EH; Pak MG; Kim K; Nam HY; Kim KM; Jung SB
Pathol Res Pract; 2020 Jul; 216(7):153013. PubMed ID: 32534715
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.
Takahashi H; Wang JP; Zheng HC; Masuda S; Takano Y
Histol Histopathol; 2011 Jun; 26(6):663-71. PubMed ID: 21472681
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
Pak MG; Koh HJ; Roh MS
Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
[TBL] [Abstract][Full Text] [Related]
4. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
5. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
Yang L; Chen Z; Xiong W; Ren H; Zhai E; Xu K; Yang H; Zhang Z; Ding L; He Y; Song X; Liu J
Hum Pathol; 2019 Feb; 84():62-70. PubMed ID: 30236596
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases.
Yun S; Lee S; Lee HY; Oh HJ; Kwak Y; Lee HS
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208855
[TBL] [Abstract][Full Text] [Related]
7. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of HSP90 isoforms and their correlations with clinicopathologic factors in patients with colorectal cancer.
Kim K; Lee HW; Lee EH; Park MI; Lee JS; Kim MS; Kim K; Roh MS; Pak MG; Oh JE; Kim KM; Lee JW; Kim TG; Nam HY
Int J Clin Exp Pathol; 2019; 12(3):978-986. PubMed ID: 31933908
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
10. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
11. Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.
Pelli A; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A; Karttunen TJ
Histopathology; 2016 Nov; 69(5):831-838. PubMed ID: 27257976
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
Boye K; Nesland JM; Sandstad B; Haugland Haugen M; Mælandsmo GM; Flatmark K
Br J Cancer; 2012 Aug; 107(4):667-74. PubMed ID: 22782346
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
14. Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis.
Semaan A; Uhl B; Branchi V; Lingohr P; Bootz F; Kristiansen G; Kalff JC; Matthaei H; Pantelis D; Dietrich D
Clin Colorectal Cancer; 2018 Jun; 17(2):e385-e393. PubMed ID: 29580650
[TBL] [Abstract][Full Text] [Related]
15. Sarco/endoplasmic reticulum calcium-ATPase 2 expression as a tumor marker in colorectal cancer.
Chung FY; Lin SR; Lu CY; Yeh CS; Chen FM; Hsieh JS; Huang TJ; Wang JY
Am J Surg Pathol; 2006 Aug; 30(8):969-74. PubMed ID: 16861967
[TBL] [Abstract][Full Text] [Related]
16. Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer.
Aldea M; Clofent J; Núñez de Arenas C; Chamorro M; Velasco M; Berrendero JR; Navarro C; Cuezva JM
Cancer Lett; 2011 Dec; 311(2):210-8. PubMed ID: 21880415
[TBL] [Abstract][Full Text] [Related]
17. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
18. Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures.
Yang YC; Chien MH; Lai TC; Su CY; Jan YH; Hsiao M; Chen CL
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316576
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of IRF-2 expression in colorectal cancer.
Mei Z; Wang G; Liang Z; Cui A; Xu A; Liu Y; Liu C; Yang Y; Cui L
Oncotarget; 2017 Jun; 8(24):38969-38977. PubMed ID: 28465494
[TBL] [Abstract][Full Text] [Related]
20. The Association Between HSP90/topoisomerase I Immunophenotype and the Clinical Features of Colorectal Cancers in Respect to
Bar JK; Lis-Nawara A; Grelewski P; Noga L; Grzebieniak Z; Jeleń M
Anticancer Res; 2017 Sep; 37(9):4953-4960. PubMed ID: 28870917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]